- Investing Ideas
- /
- Japanese Pharmaceuticals & Biotech Dividend Powerhouses (3%+ Yield)
Japanese Pharmaceuticals & Biotech Dividend Powerhouses (3%+ Yield)
Results
5
This screener pinpoints dividend all-stars that boast strong fundamentals with yields typically exceeding 3%.
5 companies
Ono Pharmaceutical
Market Cap: JP¥782.1b
Produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide.
4528
JP¥1,665.00
7D
2.6%
1Y
-29.1%
Takeda Pharmaceutical
Market Cap: JP¥6.2t
Engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally.
4502
JP¥4,065.00
7D
-2.9%
1Y
-0.7%
Nippon Shinyaku
Market Cap: JP¥236.6b
Manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally.
4516
JP¥3,512.00
7D
6.7%
1Y
-17.9%
Tsumura
Market Cap: JP¥318.3b
Manufactures and sells pharmaceutical products from crude drugs derived from plants and other natural products in Japan and internationally.
4540
JP¥4,191.00
7D
5.8%
1Y
7.1%
Seikagaku
Market Cap: JP¥36.2b
Manufactures and sells pharmaceuticals and medical devices primarily related to glycoconjugates in Japan and internationally.The company operates in two segments, Pharmaceuticals and LAL Business.
4548
JP¥664.00
7D
4.6%
1Y
-12.2%